Evidence map›Paper›PMID 24465439›Full record

ArticlePloS one2014

Aberrant activation of the WNT/β-catenin signaling pathway in lupus nephritis.

Xiao-Dong Wang, Xin-Fang Huang, Qing-Ran Yan, Chun-de Bao

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Molecular and Cellular Mediators of Renal Fibrosis in Lupus Nephritis.International journal of molecular sciences · 2025
    Review
  8. Cyclophosphamide modulates Wnt3a/β-catenin signaling in MRL/lpr mice with lupus nephritis.American journal of clinical and experimental immunology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. The Complement System, Aging, and Aging-Related Diseases.International journal of molecular sciences · 2022
    Review
  15. Review
  16. Review
  17. Article
  18. Canonical Wnt signaling in the kidney in different hypertension models.Hypertension research : official journal of the Japanese Society of Hypertension · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Xiao-Dong WangDepartment of Rheumatology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai Institute of Rheumatology, Shanghai, PR China.
Xin-Fang HuangDepartment of Rheumatology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai Institute of Rheumatology, Shanghai, PR China.
Qing-Ran YanDepartment of Rheumatology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai Institute of Rheumatology, Shanghai, PR China.
Chun-de BaoDepartment of Rheumatology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai Institute of Rheumatology, Shanghai, PR China.
Shanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe canonical WNT pathway has been implicated as playing important roles in the pathogenesis of a variety of kidney diseases. Recently, WNT pathway activity was reported to be elevated in the renal tissue of a lupus mouse model. This study aimed to evaluate the potential role of the WNT pathway in the pathogenesis of human lupus nephritis.

methodsThe expression of β-catenin was evaluated in renal biopsy specimens from lupus nephritis patients and control kidney tissues by immunohistochemistry and western blotting. Real-time polymerase chain reaction (RT-PCR) was used to detect RNA expression of β-catenin, Dkk-1 and Axin2. Plasma concentrations of Dkk-1 were measured by ELISA.

resultsImmunohistochemistry and western blotting revealed increased expression of β-catenin in the kidneys of patients with lupus nephritis compared with control kidney tissues (p<0.05), accompanied by an increase in mRNA expression of β-catenin (p<0.01) and axin2 (p<0.05). β-catenin was significantly greater in LN patients without renal interstitial fibrosis compared with those with renal interstitial fibrosis (p<0.01) at the mRNA expression level; the increase in β-catenin mRNA positively correlated with the creatinine clearance rate (Ccr) and negatively correlated with chronicity indices of renal tissue injury. Greater plasma Dkk-1 concentrations were found in LN patients compared with controls (p<0.05). Plasma Dkk-1 concentrations also correlated negatively with anti-dsDNA antibody levels and positively with serum C3 levels.

conclusionsThe canonical WNT/β-catenin signaling pathway was activated in lupus nephritis patients, accompanied by an increase in plasma levels of Dkk-1. Altered WNT/β-catenin signaling was related to the pathogenesis of lupus nephritis and might play a role in renal fibrosis.

Indexed as

AdultAntibodies, AntinuclearAxin Proteinbeta CateninCase-Control StudiesComplement C3CreatinineFemaleFibrosisGene ExpressionHumansIntercellular Signaling Peptides and ProteinsKidneyKidney Function TestsLupus NephritisMaleAntibodies, AntinuclearAXIN2 protein, humanAxin Proteinbeta CateninComplement C3CreatinineCTNNB1 protein, humanDKK1 protein, humanIntercellular Signaling Peptides and ProteinsRNA, Messenger

Identifiers

PMID24465439
PMCPMC3897389
OpenAlexW2056837060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.